Reversible Serum Carcinoembriogenic Antigen (CEA) Elevation Due to Orlistat Use: A Case Report
Open Access
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Orlistat-Associated Adverse Effects and Drug InteractionsDrug Safety, 2008
- Long-term pharmacotherapy for obesity and overweightCochrane Database of Systematic Reviews, 2003
- Carcinoembryonic antigen screening: pros and cons.1999
- Role of Orlistat in the Treatment of Obese Patients With Type 2 Diabetes: A 1-year randomized double-blind studyDiabetes Care, 1998
- Carcinoembryonic AntigenAnnals of Internal Medicine, 1986
- Carcinoembryonic antigen (CEA) as a monitor of chemotherapy in disseminated colorectal cancerCancer, 1978
- DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUESJournal of Experimental Medicine, 1965